Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 800-430-6 | CAS number: 1419212-76-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
For the test substance negative in vitro studies on skin and eye irritation and skin corrosion are available. For the analogue negative in vivo studies are available for skin and eye irritation (see rationale for read-across chapter 13).
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12-06-2013 to 17-06-2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study performed according to the guideline and under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Principles of method if other than guideline:
- exposure period 15 minutes with post-exposure incubation period of 42 hours
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Control samples:
- yes, concurrent negative control
- Details on study design:
- The EpiSKIN assay uses reconstructed human epidermis to assess skin irritation. For the viability test enzymatic conversion of MTT to formazan is used.
In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed.
In the main study triplicate tissues were treated with 30 uL of the test substance during 15 minutes. In addition a negative control (DPBS) and a positive control (5% SDS) were included. After treatment tissues were rinsed, incubated in maintenance fluid for 42 hours at 37 °C and treated with MTT during 3 hours (at 37 °C). After MTT loading a total biopsy of each epidermis (epidermis and collagen) was made, that was suspended in acidified iso-propanol for 3 days and kept in the refrigerator at 1-10°C. Thereafter the optical density of the extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control.
Tissue viability > 50% means non-irritant
Tissue viability ≤ 50% means irritant - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 81.8
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- rel viability 10.6%
- Other effects:
- The test substance did not interfere with the reduction of MTT to blue formazan salt.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance is non-irritant in the EPISKIN reconstructed human epidermal model.
Criteria used for interpretation of results: other: tissue viability > 50%: non-irritant - Executive summary:
In this assay triplicate reconstructed human skin tissues were treated with 30 uL of the test substance during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 81.8%, which is indicative for non-irritant substances.
The test substance is non-irritant in the EPISKIN reconstructed human epidermal model.
Reference
|
Mean OD562 ± SD |
Relative mean viability ± SD |
Negative control: |
0.946 ± 0.119 |
100 ± 12.6% |
Test substance: |
0.774 ± 0.021 |
81.8 ± 2.2% |
SDS: |
0.100 ± 0.014 |
10.6 ± 1.5% |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17-07-2013 to 18-07-2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: not formally validated study method
- Principles of method if other than guideline:
- The SkinEthic reconstructed human corneal epithelium assay is used
- GLP compliance:
- yes (incl. QA statement)
- Details on study design:
- The SkinEthic reconstructed human corneal epithelium assay uses corneal epithelial tissue to assess penetration and concomittant cytotoxicity of the test substance.
In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed.
In the main study triplicate SkinEthic tissues were treated with 30 uL of the test substance during 10 minutes. In addition a negative control (Na2HPO4 0.142 g/L; glucose 1.802 g/L; HEPES 7,149 g/L; KCl 0.224 g/L; NaCl 7.597 g/L) and a positive control (2% SDS) were included. After treatment tissues (3 per treatment) were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control.
Tissue viability ≥ 60% means non-irritant
Tissue viability < 60% means irritant - Irritation parameter:
- other: % tissue viability
- Value:
- 89.4
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 6.7% rel viability
- Other effects:
- The test substance did not interfere with the reduction of MTT to blue formazan salt.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance is non-irritant in the SkinEthic reconstructed human corneal epithelium assay.
Criteria used for interpretation of results: other: < 60% viability is indicative for positive result - Executive summary:
In this assay triplicate SkinEthic tissues were treated with 30 uL of the test substance during 10 minutes. After treatment tissues were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 89.4%, which is indicative for non-irritant substances.
As the assay is not formally validated, the results need to be regarded as preliminary.
Reference
|
Mean OD562 |
Relative mean viability |
Negative control: |
0.940 |
100% |
Test substance: |
0.840 |
89.4% |
SDS: |
0.063 |
6.7% |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation/corrosion
In the EPISKIN assay triplicate reconstructed human skin tissues were treated with 30 uL of the test substance during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 81.8%, which is indicative for non-irritant substances (Harlan 2013g).
In the EpiSKIN test, duplicate reconstructed human skin tissues were treated with 50 uL of the test substance during 3, 60 and 240 minutes. After treatment tissues were rinsed with PBS and incubated with MTT for 3 hours (at 37°C, 5% CO2 in air). Optical density of homogene solutions of MTT treated tissues was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 96.9 -107.4% for the different exposure times, which is indicative for non-corrosive substances (Harlan 2013h).
Eye irritation
In SkinEthic assay tissues (in triplicate) were treated with 30 uL of the test substance during 10 minutes. After treatment tissues were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 89.4%, which is indicative for non-irritant substances (Harlan 2013i).
Justification for classification or non-classification
The test substance does not need to be classified for skin and eye irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
